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A single replication fork would take more than a year to 
replicate the genome of Xenopus. By dividing the task 
among many thousands of replicons, each replicated by 
forks emanating from individual origins, replication is in- 
stead completed in as little as 30 min. While this efficient 
strategy has been adopted by all eukaryotes, it introduces 
a complication. To maintain the integrity of the genome, 
multiple replicons must now be coordinated so that all 
sequences are replicated exactly once per cell cycle. Be- 
cause different replicons are often replicated at different 
times during S phase, replicated regions must be distin- 
guishable from unreplicated regions to avoid problems of 
rereplication. We suggest that this distinction is based 
upon a fundamental feature of replication initiation. 
Two things happen at origins of replication: proteins are 
recruited to origins to assemble multiprotein replication 
machines (Figure 1, left), and these assemblies are trig- 
gered to initiate replication forks (Figure 1, right). Replica- 
tion components accompany the departing forks, leaving 
behind a spent origin. Consequently, reinitiation should 
require assembly of new components at the origin. If this 
assembly is restricted to one part of the cell cycle and the 
initiation of forks to another, then origin firing would occur 
only once per cell cycle (Figure 1). 
The transition between replication-competent and repli- 
cation-incompetent phases of the cell cycle has been ex- 
plored in a series of early and influential cell fusion experi- 
ments (Rao and Johnson, 1970). Upon fusion with an S 
phase cell, nuclei from Gl cells, but not from G2 cells, 
replicate their DNA. Thus, even when present in cytoplasm 
capable of supporting S phase, the G2 nucleus is incompe- 
tent to replicate. Since G2 nuclei are converted into Gl 
nuclei by the passage through mitosis, mitosis must pro- 
vide replication competence to the G2 nucleus. In the last 
several years, in vitro experiments using Xenopus egg 
extracts as well as genetic experiments using fission yeast 
have given rise to two rather different models for the basis 
of this mitotic transition. We outline each of these areas 
of research below and evaluate features of each model 
in an attempt to bring us closer to a unified understanding 
of these events. 
Licensing and the Minichromosome 
Maintenance Connection 
The Licensing Model 
Blow and Laskey (1988) investigated the nature of the 
mitotic transition by examining the requirements for rerep- 
lication in a Xenopus extract system. These extracts can 
assemble an intact nuclear membrane around added chro- 
matin, and the resulting nuclei can undergo multiple cycles 
of S phase and mitosis. However, when the accumulation 
of high levels of cyclin is blocked by inhibition of protein 
synthesis, the nuclei undergo a single round of DNA repli- 
cation and arrest in G2 phase. Blow and Laskey found 
that they could bypass the requirement for mitosis and 
induce another round of replication by permeabilizing the 
nuclei with detergents or mechanical disruption. They pro- 
posed that the nuclear membrane excludes an essential 
replication factor that “licenses” the DNA for replication 
and that this factor is inactivated or destroyed in conjunc- 
Figure 1. A Model for Limiting DNA Replica- 
tion to Once per Cell Cycle 
Formation of a functional replication origin 
(green) involves assembly of essential replica- 
tion factors (blue spheres) onto DNA at a site 
marked by an origin recognition complex 
(ORC) (gray spheres). Origin firing (pink) in- 
volves the initiation of replication forks from 
assembled origins. Some replication factors 
travel with the fork, while others dissociate or 
remain at the origin, resulting in a spent origin. 
Assembly and firing of origins are confined to 
different parts of the cell cycle (green and pink, 
respectively), thereby limiting initiation of DNA 
replication to once per cell cycle. 
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tion with replication. Accordingly, G2 nuclei lack active 
licensing factor, and replication is thus prohibited until the 
nuclear envelope breaks down during mitosis (or upon 
experimental manipulation), allowing entry of new factor. 
In thecontextof Figure 1, admissionoftheessential licens- 
ing factor at mitosis allows the assembly of replication 
proteins at origins, and the destruction of this licensing 
factor upon origin firing prevents further assembly during 
the replication phase. 
The Minichromosome Maintenance Gene Family 
The finding that the protein encoded by the Saccharo- 
myces cerevisiae gene CDC46 is required for DNA replica- 
tion and is present in the nucleus only from mitosis until S 
phase led to the suggestion that it might provide licensing 
function (Hennessy et al., 1990). Since then, CDC46 has 
been shown to belong to a family of genes, called MCMs 
(for minichromosome maintenance genes), many of which 
were identified in screens for mutations that increase the 
rate of plasmid loss. Several experiments indicate that 
MCM genefunction is required at origins for the initiation 
of replication. Among these is the finding that CDC46 inter- 
acts genetically with ORC-6, which encodes a subunit of a 
multiprotein complex that binds to yeast replication origins 
and is required for DNA replication (Li and Herskowitz, 
1993). 
Isolation of MCM homologs in Schizosaccharomyces 
pombe (Coxon et al., 1992), Drosophila (Treisman et al., 
1995), Xenopus (Coxon et al., 1992), mammals (Hu et al., 
1993), and Arabidopsis (Springer et al., 1995) has demon- 
strated their conservation among eukaryotes. In mamma- 
lian cells, MCM gene products are nuclear throughout in- 
terphase, but their staining pattern, Triton X-100 extract- 
ability, and phosphorylation differ between Gl and G2 
phases (Kimura et al., 1994). These differences might re- 
flect changes in assembly or activity and thus be consis- 
tent with a licensing role for these proteins. 
The Licensing Model Meets the MCMs 
In an exciting intersection of two previously independent 
fields, several groups have shown involvement of MCM 
proteins in the licensing process as assayed in Blow and 
Laskey-type in vitro systems. Madine et al. (1995) demon- 
strated that permeabilized HeLa G2 nuclei replicate in a 
complete Xenopus egg extract, but not in one immunode- 
pleted for a Xenopus MCM3 homolog and its associated 
proteins (notably, the associated proteins included three 
additional MCM family members). In contrast, permeabil- 
ized HeLa Gl nuclei underwent a complete round of repli- 
cation in the immunodepleted extract. These results indi- 
cate that, while Xenopus MCM3 and associated proteins 
are required for the replication of G2 nuclei, they have 
either executed their function prior to Gl phase or are 
associated with the Gl nuclei. 
Chonget al. (1995)and Kubotaet al. (1995) tookasome- 
what different approach to address the role of MCMs in 
licensing. They used assays based on the previous obser- 
vation that when chromatin is added to mitotic Xenopus 
egg extracts that have been treated with kinase inhibitors, 
it is assembled into a nucleus but fails to undergo DNA 
replication. Replication can ensue, however, if the chro- 
matin is first exposed to a membrane-depleted interphase 
extract that is itself incapable of supporting nuclear enve- 
lope assembly and chromatin replication. The activity pro- 
vided by these “impaired” interphase extracts is presumed 
to be licensing factor. Crude subdivision of the impaired 
extract produced two fractions (RLF-M and RLF-B) that 
together, but not alone, supported licensing (Chong et al. 
1995). The activity in one of these fractions (RLF-M) was 
purified to three proteins, including an MCM3 homolog 
and a second, uncharacterized MCM homolog. Immuno- 
depletion of MCM3 and associated proteins eliminated 
licensing activity from the impaired interphase extract. Us- 
ing a similar approach, Kubota et al. (1995) purified three 
proteins that bound to chromatin during incubation in a 
similarly impaired interphase extract that is licensing com- 
petent, but did not bind in a treated mitotic extract that 
is licensing incompetent. The cDNA encoding one of the 
purified proteins, ~100, was found to be homologous to 
yeast MCM3. lmmunodepletion of ~100 was sufficient to 
remove licensing activity from impaired interphase ex- 
tracts. 
Although these papers demonstrate that MCM homo- 
logs or their associated proteins are required for replica- 
tion of G2 nuclei, there are several reasons to suspect 
that the MCM gene products may not be the licensing 
factors postulated by Blow and Laskey (1988). The obser- 
vations that the MCMs are required for the replication of 
G2 nuclei and that they may become stably associated 
with chromatin upon transition from G2 to Gl are consis- 
tent with the predictions of the licensing model, but are 
not sufficient to define the licensing factor. Any replication 
protein such as RPA, which is assembled into “prereplica- 
tion centers” immediately following mitosis (Adachi and 
Laemmli, 1992), might show such behavior. Furthermore, 
in contrast with the predictions of the licensing model, two 
groups (Kimura et al., 1994; Madine et al., 1995) have 
demonstrated that MCM3 homologs can enter a Gl nu- 
cleus in the absence of nuclear membrane breakdown. 
For this reason, Chong et al. (1995) raise the possibility 
that their identified MCM fraction (RLF-M) is not itself the 
licensing factor, but is rather an essential replication func- 
tion whose action depends upon an additional factor (pres- 
ent in the crude RLF-B fraction) that is regulated by nuclear 
entry. Thus, although these papers define several mole- 
cules that participate in the process whereby a G2 nucleus 
can acquire the license to replicate, they fail to shed new 
light on the mechanism by which this is normally pre- 
vented. 
Cyclin-Dependent Kinases and Rereplication 
The study of mutations in yeast that allow replication of 
G2 nuclei has provided insight into how this replication 
is normally prevented. Broek et al. (1991) attempted to 
identify genes involved in the prevention of rereplication 
in S. pombe in a screen for mutations that allowed haploid 
cells to sporulate; because sporulation can only occur in 
diploid cells, mutations identified in this screen were ex- 
pected to have caused endoreplication. They identified 
two mutations that provoked an additional round of S 
phase that gave rise to viable diploid cells. Remarkably, 
both of these mutations were alleles of c&2, which en- 
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codes thecyclin-dependent kinase(CDK)of thisorganism. 
Recently, a more direct screen for mutations that allow 
endoreplication identified three mutations (Hayles et al., 
1994). Two of these mutations represent additional alleles 
of c&2, and the third is in c&73, which encodes the G2 
cyclin partner of c&2. These results provide compelling 
evidence that the cyclin-Cdc2 complex plays a role in 
preventing rereplication during G2. They also provide 
a general model for the control of replication within the 
cell cycle, because cyclin-CDK complexes are present 
throughout S and G2 phases when licensing is prohibited. 
The coupling of mitosis to the ability to rereplicate is pro- 
vided in this model by the cyclin destruction and resulting 
elimination of CDK activity that universally accompany mi- 
tosis. In addition to simply regulating licensing, the pres- 
ence of this complex appears to define G2 phase itself 
because when the complex is eliminated, the cells appar- 
ently enter Gl phase (Broek et al., 1991). 
Because the yeast nuclear envelope remains intact dur- 
ing mitosis, the licensing model does not explain the block 
to rereplication in yeast. For this reason, perhaps, studies 
in S. pombe and Xenopus have largely progressed inde- 
pendently of one another. But there are reasons to believe 
that the role of CDKs in licensing is universal. For example, 
mutations in Drosophila cyclin A lead to endoreplication 
in normally mitotic cells (Sauer et al., 1995). In mammals, 
the addition of a tyrosine kinase inhibitor to cultured cells 
also induces endoreplication (Usui et al., 1991). This in- 
verse relationship of kinase levels and the ability to rerepli- 
cate is also supported by correlations seen in cell cycles 
that lack the regular alternation of S phase and mitosis. 
For example, endocycles in Drosophila, which consist of 
multiple rounds of S phase without intervening mitoses, 
also lack the G2 cyclins A and B (Lehner and O’Farrell, 
1990). A second example is provided by meiosis, which 
consists of two mitotic-like states without intervening S 
phase and therefore can be seen as a cycle that lacks 
licensing. The decline in CDK activity at meiosis I is incom- 
plete. If this residual activity is further reduced by dominant 
negative CDK expression, then meiosis I is followed by S 
phase rather than meiosis II (Furuno et al., 1994). 
A role for CDKs in preventing rereplication can easily 
be incorporated into the view represented in Figure 1. We 
suggest that CDKs couple replication and the cell cycle in 
two ways. First, they prevent the recruitment of replication 
proteins to origins in 62, thereby preventing rereplication. 
This supposition has been supported by the demonstra- 
tion that CDKs inhibit assembly of “prereplication centers” 
in Xenopus egg extracts (Adachi and Laemmli, 1994). Sec- 
ond, since CDK activity is required for S phase, the rise 
in CDK associated with entry into S phase would terminate 
the period during which replication proteins can assemble 
at origins. 
In several circumstances, the state of a nucleus appears 
to be determined independently of the state of the cyto- 
plasm. For example, under certain situations, adjacent 
nuclei in a syncytial Drosophila embryo can be in entirely 
different phases of the cell cycle (e.g., only one of four 
products of female meiosis enters interphase, and a local 
cluster of blastoderm nuclei can undergo an additional 
cycle to compensate for low nuclear density). And as 
shown in the work of Rao and Johnson (1970), when Gl 
and G2 cells are fused to each other, the two nuclei con- 
tinue to behave differently. These results can be explained 
in terms of the kinase model if one assumes that nuclei 
constitute discrete domains of kinase activity. In this way, 
a nucleus could retain a particular level of kinase even 
when sharing cytoplasm with a nucleus that has a different 
level. 
The Qualifications for License 
The licensing model and the kinase model are at odds 
over one prediction. In the licensing model, acquisition of 
the license to replicate is coupled to mitosis by a require- 
ment for nuclear membrane breakdown, while in the ki- 
nase model, the coupling is due to a requirement for a 
collapse in nuclear kinase activity. The genetic finding that 
removal of kinase during G2 leads to rereplication (in the 
absence of nuclear membrane breakdown) cannot easily 
be explained by the licensing model. But we suggest that 
the observation that nuclear membrane permeabilization 
allows rereplication in an extract system can be explained 
by the kinase model. If disruption of the nuclear membrane 
in the presence of egg extract destroys a nuclear compart- 
ment of kinase activity, then it could mimic the normal 
mitotic collapse of the nuclear kinase activity. We suggest 
that the licensing factor proposed by Blow and Laskey 
(1988) responds not to nuclear envelope breakdown but 
rather to CDK levels. 
If the elimination of CDKs is what qualifies a nucleus 
for licensing, what role is played by the MCM proteins? 
We suggest that these proteins associate with origins and 
promote the assembly of functional initiation complexes 
and that their interaction with chromatin is prevented dur- 
ing Sand G2 phases by CDK-mediated modifications. This 
proposal is based on the requirement for MCM proteins 
for replication initiation in yeast, their genetic interactions 
with a yeast origin-binding protein, and their differing phos- 
phorylation and chromatin association between Gl and 
G2 phases in mammals. 
If the proposed assembly of proteins at an origin corre- 
sponds to the license to replicate, then an analysis of such 
assembly could provide a physical assay for licensing. 
Interestingly, the DNA footprint observed at replication ori- 
gins in yeast changes during the cell cycle (Diffley et al., 
1994). During the S and 62 phases, the footprint is identi- 
cal to that seen in vitro with purified origin recognition 
complex (ORC). During Gl phase, however, the ORC foot- 
print is extended, indicating the presence of additional 
proteins. We suggest that this extension of the footprint 
during Gl corresponds to the MCM-dependent assembly 
of a licensed origin (Figure 1) and that the analysis of this 
process will define the events that qualify an origin for 
licensing. 
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